Ariadne Technology Licensed by Takeda for Evaluation of Potential Antibody Targets

Ariadne announces that Takeda San Francisco, Takeda’s global center for excellence for biologics, has signed an agreement to license Ariadne’s Pathway Studio® software. Takeda plans to utilize the software and underlying text-mining algorithms in their discovery program against cancer, inflammatory and metabolic diseases.

Source: Ariadne